www.Top100Pharmacy.com - TOP 100 PHARMACY SITES
TOP 100 PHARMACY SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Mon, June 16, 2008.
251.www.knmp.nl11000
252.www.sanofipasteur.com10900
253.www.astrazeneca.fr10900
254.www.bayervital.de10900
255.www.altana.com10900
256.www.ambien.com10800
257.www.pfizer.ch10800
258.www.exelixis.com10700
259.www.biospecifics.com10700
260.www.tylenol.com10600
261.www.bionorica.de10600
262.www.nycomed.ru10500
263.www.astrazeneca.de10500
264.www.menarini.com10300
265.www.ferring.com10200
266.www.clinicalneuropharm.com10000
267.www.pfizer.no9980
268.www.takeda.com9780
269.www.ebdgroup.com9700
270.www.alpharma.com9690
271.www.bavarian-nordic.com9650
272.www.guild.org.au9630
273.www.farmasalute.it9590
274.www.mochida.co.jp9550
275.www.breggin.com9450
276.www.factsandcomparisons.com9430
277.www.farmamondo.com9410
278.www.creapharma.ch9410
279.pharmacy.ouhsc.edu9380
280.www.florahealth.com9360
281.www.mdsps.com9330
282.www.cuttingedgeinfo.com9140
283.www.medsmex.com6680
284.www.feelbest.com6300
285.www.candrugstore.com6110
286.www.nymox.com5920
287.www.treatingyourself.com5810
288.zocor.com5690
289.www.epharma.md5350
290.www.nutropin.com4670
291.www.iberogast.de4340
292.www.glivec.com4310
293.www.paxil.com4030
294.1800patches.com3940
295.www.curis.com3580
296.www.xeloda.com3570
297.us.boehringer-ingelheim.com3520
298.www.nastech.com3470
299.www.uhlmann.de3260
300.www.intermune.com3250
Pages:  1  2  3  4  5  6  7  8  9  10 


Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Furl Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Ma.gnolia Add to Newsvine Add to Shadows

298. www.nastech.com

Rating: 3470 points*
*amount mentions of word 'www.nastech.com' on the other websites

www.nastech.com

Nastech: Improving pharmaceutical drug products through nasal drug delivery technologies

Description: Nastech Pharmaceutical Company Inc. is an emerging pharmaceutical company dedicated to the development and commercialization of innovative drug delivery technologies and products. The Company's proprietary technologies focus on the delivery of small and large molecule drugs by nasal administration.

Most popular searches: www.astech.com, www.anstech.com, nascobal, ww.nastech.com, wwwnastech.com, hepatitis b, systemic transnasal absorption technology, www.nastceh.com, www.nastech.ocm, intranasal, pain management, www.nastehc.com, apo, B12 deficiency, www.natech.com, growth deficiency, nastech pharmaceutical company, hepatic illnesses, www.nastch.com, pts, www.nstech.com, www.nastech.cmo, female sexual dysfunction, sexual dysfunction, www.nasteh.com, nstk, migraine, hepatitis c, multiple sclerosis, www.nasech.com, www.nastech, fsd, www.nastech.cm, www.nasetch.com, www.nastec.hcom, breakthrough pain, paracellular transport system, wwwn.astech.com, wwwnastech.com, www.nastech.om, erectile dysfunction, www.nastech.co, www.nastech.com, www.nastechcom, ww.wnastech.com, www.nsatech.com, www.nastec.com, www.nastechc.om, ww.nastech.com, intranasal drug delivery, cancer, motion sickness, sta-t, www.natsech.com

Google

© 2005-2008 www.Top100Pharmacy.com
Newsweek: Where not to have a heart attack
A new study finds dramatic regional differences in cardiac-arrest survival rates. Why some places are better than others when it comes to saving lives.
newsweek.com
Calif. hospitals settle patient-dumping lawsuit
A $1.6 million settlement has been reached with two Southern California hospitals accused of improperly discharging and dumping psychiatric patients on Skid Row in Los Angeles.
msnbc.msn.com
Glaxo to Acquire Lab for $2.9 Billion
GlaxoSmithKline, the British drug company, will acquire Stiefel Laboratories, the companies said Monday.
nytimes.com
Senate Panel Rejects Bid to Add Drug Discount
The Finance Committee will not require pharmaceutical companies to give bigger discounts to Medicare on drugs for older Americans with low incomes.
nytimes.com
European Court Sides With Drug Companies Over Pricing Matter
The decision, in a case involving GlaxoSmithKline, is a blow to governments in northern Europe looking to keep costs down.
nytimes.com